Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 16Thoracic 3Head & Neck 2Gynecologic 2Endocrine 2Other neoplasm 1NET 1Genitourinary 1

Conditions

Lung Neoplasms 2Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Conversion to Open Surgery × Thoracic × Clear all
NCT04009915 2022-05-09

VOLCANO

Shanghai Pulmonary Hospital, Shanghai, China

Phase 3 Unknown
200 enrolled
Thoracic

Lung Neoplasms

NCT03521375 2020-09-22

VIOLET

University of Bristol

Phase NA Completed
503 enrolled
Thoracic

Lung Neoplasms, Neoplasms

NCT02360761 2016-09-20

STEPS

Peking University People's Hospital

Phase 3 Unknown
339 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡